Solicitation of Nominations for Appointment to the Advisory Committee to the Director, Centers for Disease Control and Prevention; Notice of Extension, 46889 [2024-11871]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 105 / Thursday, May 30, 2024 / Notices
46889
PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTING)—Continued
KQ1
Inclusion
Outcome Timing .......
Post-operative period ≤3 months subdivided into 72 hours
or less; >72 hours or discharge up to <30 days; 30 days
up to ≤3 months.
Post-operative period 3–12 months.
Perioperative (inpatient or outpatient) setting for intervention.
Perioperative and all follow-up settingsfor outcomes.
Randomized controlled trials (RCTs).
Minimum sample size per arm of ≥30 participants. If a particular intervention/comparator is not represented in the
studies of 30/arm or greater, we will include studies of
smaller size for that unique intervention/comparator.
English-only peer-reviewed publications from 2013. (Consistent with other current ASA systematic reviews on regional anesthesia.)
Setting ......................
Study design ............
Publications ..............
Exclusion
Other timing.
Nerve blocks performed in the outpatient clinic.
Nerve blocks performed outside of the preoperative day-ofsurgery to the 24-hours postoperative.
Non-randomized, observational, non-controlled study designs, cross-sectional, prevalence, qualitative, case reports, opinions/letters, pilot studies, feasibility studies.
Studies with a sample size <30 participants analyzed in
any arm.
Comments, editorials, and letters.
* EMERGENCY—A surgical, therapeutic, or diagnostic procedure that cannot be delayed without causing a significant risk of death or permanent impairment. Note: The American Society of Anesthesiologists (ASA) Physical Status should include ‘‘E’’. The designation of a procedure as
an emergency is determined by a surgeon and/or an anesthesiologist.
URGENT—A surgical, therapeutic, or diagnostic procedure that must be performed to prevent death or permanent impairment but that can be
delayed. Note: The procedure may be delayed to allow for medical optimization of the patient or to permit better availability of resources (e.g.,
personnel or equipment).
ELECTIVE—A surgical, therapeutic, or diagnostic procedure that can be performed at any time or date with an agreement between the surgeon and the patient.
Dated: May 22, 2024.
Marquita Cullom,
Associate Director.
membership on the ACD, CDC must be
received no later than July 8, 2024. Late
nominations will not be considered for
membership.
[FR Doc. 2024–11834 Filed 5–29–24; 8:45 am]
BILLING CODE 4160–90–P
All nominations (cover
letters, reference letters, and curriculum
vitae/resumes) should be emailed to
ACDirector@cdc.gov with the subject
line: ‘‘Nomination for CDC ACD.’’
ADDRESSES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention, Department of Health and
Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Committee to the Director, Centers for
Disease Control and Prevention (ACD,
CDC). The ACD, CDC consists of up to
15 experts knowledgeable in areas
pertinent to the CDC mission, such as
public health, global health, health
disparities, biomedical research, and
other fields, as applicable.
DATES: The deadline for submission of
nominations for membership on the
ACD, CDC published May 8, 2024, at 89
FR 38900, is extended. Nominations for
ddrumheller on DSK120RN23PROD with NOTICES1
VerDate Sep<11>2014
20:03 May 29, 2024
Jkt 262001
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–11871 Filed 5–29–24; 8:45 am]
BILLING CODE 4163–18–P
FOR FURTHER INFORMATION CONTACT:
Solicitation of Nominations for
Appointment to the Advisory
Committee to the Director, Centers for
Disease Control and Prevention;
Notice of Extension
SUMMARY:
Prevention and the Agency for Toxic
Substances and Disease Registry.
Tiffany Brown, J.D., M.P.H., Office of
the Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H21–10, Atlanta,
Georgia 30329–4027. Telephone: (404)
498–6655; Email: ACDirector@cdc.gov.
SUPPLEMENTARY INFORMATION:
The
deadline for nominations for
appointment to the Advisory Committee
to the Director, Centers for Disease
Control and Prevention has been
extended from June 7, 2024, to July 8,
2024. The original solicitation of
nominations notice was published in
the Federal Register on May 8, 2024,
Volume 89, Number 90, page 38900.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget Review; Family Violence
Prevention and Services Grants to
States; Native American Tribes and
Alaskan Native Villages; and State
Domestic Violence Coalitions (Office of
Management and Budget #0970–0280)
Office of Family Violence
Prevention and Services;
Administration for Children and
Families; Department of Health and
Human Services.
ACTION: Request for public comments.
AGENCY:
The Family Violence
Prevention and Services Act (FVPSA)
program within the Office of Family
Violence Prevention and Services
(OFVPS) plans revised program
announcements and minor changes to
the previously approved Performance
Progress Report for States and Tribes
(Office of Management and Budget
(OMB) #0970–0280; Expiration Date:
May 31, 2024). Minor changes are
SUMMARY:
E:\FR\FM\30MYN1.SGM
30MYN1
]]>Agencies
[Federal Register Volume 89, Number 105 (Thursday, May 30, 2024)]
[Notices]
[Page 46889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11871]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee to the Director, Centers for Disease Control and Prevention;
Notice of Extension
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS), is seeking nominations for
membership on the Advisory Committee to the Director, Centers for
Disease Control and Prevention (ACD, CDC). The ACD, CDC consists of up
to 15 experts knowledgeable in areas pertinent to the CDC mission, such
as public health, global health, health disparities, biomedical
research, and other fields, as applicable.
DATES: The deadline for submission of nominations for membership on the
ACD, CDC published May 8, 2024, at 89 FR 38900, is extended.
Nominations for membership on the ACD, CDC must be received no later
than July 8, 2024. Late nominations will not be considered for
membership.
ADDRESSES: All nominations (cover letters, reference letters, and
curriculum vitae/resumes) should be emailed to [email protected] with
the subject line: ``Nomination for CDC ACD.''
FOR FURTHER INFORMATION CONTACT: Tiffany Brown, J.D., M.P.H., Office of
the Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027.
Telephone: (404) 498-6655; Email: [email protected].
SUPPLEMENTARY INFORMATION: The deadline for nominations for appointment
to the Advisory Committee to the Director, Centers for Disease Control
and Prevention has been extended from June 7, 2024, to July 8, 2024.
The original solicitation of nominations notice was published in the
Federal Register on May 8, 2024, Volume 89, Number 90, page 38900.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-11871 Filed 5-29-24; 8:45 am]
BILLING CODE 4163-18-P
